| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0002 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.0002 |